Literature DB >> 19854080

Pharmacokinetics of oral gabapentin in greyhound dogs.

Butch Kukanich1, Rachael L Cohen.   

Abstract

The purpose of this study was to assess the pharmacokinetics of gabapentin in healthy greyhound dogs after single oral doses targeted at 10 and 20mg/kg PO. Six healthy greyhounds were enrolled (3 males, 3 females). Blood was obtained at predetermined times for the measurement of gabapentin plasma concentrations by liquid chromatography/mass spectrometry. Pharmacokinetic parameters were determined with computer software. The actual mean (and range) doses administered were 10.2 (9.1-12.0) mg/kg and 20.5 (18.2-24) mg/kg for the 10mg/kg and 20mg/kg targeted dose groups. The mean C(MAX) for the 10 and 20mg/kg groups were 8.54 and 13.22 microg/mL at 1.3 and 1.5h, and the terminal half-lives were 3.3 and 3.4h, respectively. The relative bioavailability of the 10mg/kg group was 1.13 compared to the 20mg/kg group. Gabapentin was rapidly absorbed and eliminated in dogs, indicating that frequent dosing is needed to maintain minimum targeted plasma concentrations. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854080      PMCID: PMC2891228          DOI: 10.1016/j.tvjl.2009.09.022

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

1.  Clinical diagnosis and treatment of suspected neuropathic pain in three dogs.

Authors:  R G Cashmore; T R Harcourt-Brown; P M Freeman; N D Jeffery; N Granger
Journal:  Aust Vet J       Date:  2009 Jan-Feb       Impact factor: 1.281

Review 2.  Adjunctive analgesic therapy in veterinary medicine.

Authors:  Leigh A Lamont
Journal:  Vet Clin North Am Small Anim Pract       Date:  2008-11       Impact factor: 2.093

3.  Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.

Authors:  M Govendir; M Perkins; R Malik
Journal:  Aust Vet J       Date:  2005-10       Impact factor: 1.281

4.  Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy.

Authors:  S R Platt; V Adams; L S Garosi; C J Abramson; J Penderis; A De Stefani; L Matiasek
Journal:  Vet Rec       Date:  2006 Dec 23-30       Impact factor: 2.695

5.  Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors:  K O Vollmer; A von Hodenberg; E U Kölle
Journal:  Arzneimittelforschung       Date:  1986-05

6.  In Vitro/in vivo relationship of gabapentin from a sustained-release tablet formulation: a pharmacokinetic study in the beagle dog.

Authors:  Yun-Seok Rhee; Seok Park; Tae-Won Lee; Chun-Woong Park; Tae-Young Nam; Tack-Oon Oh; Ji-Woong Jeon; Sang Beom Han; Dong-Soo Lee; Eun-Seok Park
Journal:  Arch Pharm Res       Date:  2008-08-14       Impact factor: 4.946

7.  Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.

Authors:  L L Radulovic; D Türck; A von Hodenberg; K O Vollmer; W P McNally; P D DeHart; B J Hanson; H N Bockbrader; T Chang
Journal:  Drug Metab Dispos       Date:  1995-04       Impact factor: 3.922

Review 8.  Mechanisms of the antinociceptive action of gabapentin.

Authors:  Jen-Kun Cheng; Lih-Chu Chiou
Journal:  J Pharmacol Sci       Date:  2006-02-11       Impact factor: 3.337

  8 in total
  7 in total

1.  Post-stroke pain hypersensitivity induced by experimental thalamic hemorrhage in rats is region-specific and demonstrates limited efficacy of gabapentin.

Authors:  Fei Yang; Han Fu; Yun-Fei Lu; Xiao-Liang Wang; Yan Yang; Fan Yang; Yao-Qing Yu; Wei Sun; Jia-Shuang Wang; Michael Costigan; Jun Chen
Journal:  Neurosci Bull       Date:  2014-11-05       Impact factor: 5.203

2.  Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy.

Authors:  Giulianne Carla Crociolli; Renata Navarro Cassu; Rafael Cabral Barbero; Thalita Leone A Rocha; Denis Robson Gomes; Gabriel Montoro Nicácio
Journal:  J Vet Med Sci       Date:  2015-03-29       Impact factor: 1.267

3.  Plasma disposition of gabapentin after the intragastric administration of escalating doses to adult horses.

Authors:  Jenifer R Gold; Tamara L Grubb; Stephen Green; Sherry Cox; Nicolas F Villarino
Journal:  J Vet Intern Med       Date:  2020-02-08       Impact factor: 3.333

4.  Pharmacokinetics and pharmacodynamics of repeat dosing of gabapentin in adult horses.

Authors:  Jenifer R Gold; Tamara L Grubb; Sherry Cox; Lais Malavasi; Nicholas L Villarino
Journal:  J Vet Intern Med       Date:  2022-02-12       Impact factor: 3.333

Review 5.  Proposed Canadian Consensus Guidelines on Osteoarthritis Treatment Based on OA-COAST Stages 1-4.

Authors:  Conny Mosley; Tara Edwards; Laura Romano; Geoffrey Truchetti; Laurie Dunbar; Teresa Schiller; Tom Gibson; Charles Bruce; Eric Troncy
Journal:  Front Vet Sci       Date:  2022-04-26

Review 6.  Managing Neuropathic Pain in Dogs.

Authors:  Sarah A Moore
Journal:  Front Vet Sci       Date:  2016-02-22

7.  The pharmacokinetics of gabapentin in cats.

Authors:  Derek Adrian; Mark G Papich; Ronald Baynes; Emma Stafford; B Duncan X Lascelles
Journal:  J Vet Intern Med       Date:  2018-10-11       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.